Clinical trial
Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in…
NCT00134979 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00134979 |
|---|---|
| Title | Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease |
| Official title | Efficacy and Safety of Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Collaborators | Pacira Pharmaceuticals, Inc Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Formoterol |
| Enrollment | 847 |
| Start date | Oct 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Aug 25, 2005 |
| Last update posted | Oct 25, 2011 |
| Countries | Switzerland |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: